| |
| |
|
| Insider
Information: |
Weiser Michael |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
4,915,553 |
|
|
Indirect Shares
|
28,484 |
|
|
| Direct
Value |
$39,424,791 |
|
|
|
Indirect Value
|
$312,327 |
|
|
| Total
Shares |
4,944,037 |
|
|
| Total
Value |
$39,737,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 9.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
TG Therapeutics Inc |
TGTX |
Former Director |
2010-03-08 |
2,292,241 |
2003-11-26 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2017-12-30 |
224,282 |
2005-09-13 |
0 |
Premium* |
|
|
Vioquest Pharmaceuticals |
VOQP |
Director |
2005-10-18 |
1,612,068 |
2005-10-18 |
0 |
Premium* |
|
|
Chem Rx Corporation |
CHRXU |
Officer, Director |
2005-10-21 |
106,250 |
|
0 |
Premium* |
|
|
Emisphere Technologies Inc |
EMIS |
Director |
2008-08-13 |
6,413 |
2006-05-26 |
0 |
Premium* |
|
|
Talon Therapeutics Inc |
TLON |
Director |
2008-05-15 |
561,667 |
2006-07-11 |
0 |
Premium* |
|
|
Chelsea Therapeutics Internation... |
CHTP |
Director |
2014-06-23 |
0 |
2006-08-23 |
0 |
Premium* |
|
|
Iovance Biotherapeutics Inc |
IOVA |
Director |
2022-05-31 |
112,632 |
2022-05-31 |
28,484 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CHRXU |
Chem Rx Corporation |
Executive Vice PresidentOffice |
• • – |
2005-10-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
106,250 |
|
- |
|
| TLON |
Talon Therapeutics Inc |
Director |
– • – |
2006-07-11 |
4 |
B |
$7.83 |
$7,888 |
D/D |
1,000 |
551,667 |
2.39 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2006-08-23 |
4 |
B |
$3.27 |
$3,270 |
D/D |
1,000 |
434,085 |
2.31 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2008-10-03 |
4 |
B |
$2.76 |
$2,760 |
D/D |
1,000 |
426,585 |
2.31 |
- |
|
| EMIS |
Emisphere Technologies In... |
Director |
– • – |
2006-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,115 |
1,115 |
|
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2008-09-24 |
4 |
B |
$2.99 |
$4,490 |
D/D |
1,500 |
425,585 |
2.31 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2012-12-31 |
4 |
D |
$4.21 |
$8,016 |
D/D |
(1,904) |
176,886 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2014-12-31 |
4 |
D |
$5.07 |
$10,378 |
D/D |
(2,047) |
166,934 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2015-12-31 |
4 |
D |
$8.31 |
$17,011 |
D/D |
(2,047) |
164,887 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2014-12-30 |
4 |
D |
$5.03 |
$10,317 |
D/D |
(2,051) |
168,981 |
0 |
- |
|
| EMIS |
Emisphere Technologies In... |
Director |
– • – |
2008-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,638 |
6,413 |
0 |
- |
|
| EMIS |
Emisphere Technologies In... |
Director |
– • – |
2007-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,660 |
3,775 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2007-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,225 |
2,217,563 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2006-07-12 |
4 |
B |
$0.72 |
$3,696 |
D/D |
5,000 |
2,213,338 |
2.31 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2012-06-05 |
4 |
B |
$1.32 |
$6,600 |
D/D |
5,000 |
450,178 |
2.39 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2013-12-31 |
4 |
D |
$4.34 |
$25,406 |
D/D |
(5,854) |
171,032 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2017-12-30 |
4 |
D |
$4.14 |
$24,927 |
D/D |
(6,021) |
224,282 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2009-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
135,945 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2016-12-31 |
4 |
D |
$5.35 |
$49,921 |
D/D |
(9,331) |
203,670 |
0 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2007-05-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
424,085 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2007-07-12 |
4 |
A |
$0.38 |
$3,800 |
D/D |
10,000 |
2,227,563 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2007-07-16 |
4 |
A |
$0.33 |
$3,300 |
D/D |
10,000 |
2,237,563 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2007-08-01 |
4 |
A |
$0.26 |
$2,600 |
D/D |
10,000 |
2,247,563 |
0 |
- |
|
| TLON |
Talon Therapeutics Inc |
Director |
– • – |
2008-05-15 |
4 |
B |
$0.84 |
$8,440 |
D/D |
10,000 |
561,667 |
2.39 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Director |
– • – |
2022-05-31 |
4 |
B |
$6.79 |
$67,978 |
D/D |
10,000 |
112,632 |
2.39 |
% |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
